Clinical Study, January 2026: Patient Perspectives on Immediate Zirconia Implant Therapy

Patient Perspectives on Immediate Zirconia Implant Therapy: Long-Term Multicenter Study

Introduction

Immediate zirconia implant placement minimizes surgical interventions, shortens healing, and preserves bone and soft tissue contours. While clinical success is established, this multicenter study evaluates patient-reported outcomes (PROMs) across Austria, Spain, and Germany, assessing satisfaction, function, pain, and social impact over 8 years.

Objectives

• Assess patient satisfaction with function, esthetics, and comfort.
• Evaluate quality-of-life improvements following immediate zirconia implant therapy.
• Identify clinical factors influencing patient experience.

Methodology

• 54 patients received 272 zirconia implants in a standardized immediate placement protocol.
• PROMs were collected before implantation (T0) and at final prosthetic restoration (T1) using a 0–10 Visual Analog Scale.
• Domains assessed: functional limitation, psychological discomfort, physical pain, physical and social disability, and handicap.
• Clinical variables: implant diameter, number, augmentation procedures, timing of loading.
• Follow-up: mean 8.1 ± 1.5 years; survival rate recorded.

Clinical Relevance

• Immediate zirconia implants provide high patient satisfaction and excellent esthetic outcomes.
• PROMs highlight improvements in chewing, speaking, comfort, and social confidence.
• Use of augmentation and careful planning enhances patient-perceived benefits.

Conclusion

Immediate zirconia implants demonstrate excellent long-term outcomes with 100% survival and a 94.99% overall patient satisfaction rate. PROMs confirm functional, esthetic, and psychosocial improvements, supporting zirconia implants as a predictable, patient-centered treatment option.

References

The full study is published in the Journal of Oral Implantology 2025, Vol. 51, No. 5.
The study can be requested from us via email: marketingsds@swissdentalsolutions.com or purchased through PubMed: https://pubmed.ncbi.nlm.nih.gov/40566728/

Co-authors of the study:

Prof. Dr. med. dent. E. Schnurr (Scientific Advisor, SDS)

Provides scientific guidance for SWISS DENTAL SOLUTIONS. She researches the oral microbiome, biofilm infections, and their impact on overall health: from clinical research and data analysis to drug development.

@ Email 🔗 Website

Dr. Mario Parra MSc.

Dr. Mario Parra is a pioneer of the Swiss Biohealth Concept in Spain. He is the first and only Spanish dentist certified in biological dentistry and ceramic implantology, and an official ambassador for excellence in ceramic implants.

@ Email 🔗 Website

Dr. med. dent. Fabian Schick

Dr. Fabian Schick is a specialist in biological dentistry and ceramic implants (ISMI/IAOCI). His focus is on metal-free, immunologically compatible dentistry that enhances health while delivering aesthetically excellent long-term results.

@ Email 🔗 Website

Dr. Robert Bauder, MSc. MSc.

Dr. Robert Bauder, MSc. MSc. is a specialist in biological dentistry, aesthetic metal-free full-ceramic restorations, ceramic implants, periodontology, and CAD/CAM immediate restorations.

@ Email 🔗 Website

Dr. Benedikt Langwieder

Dr. Benedikt Langwieder studied dentistry at LMU Munich (2011–2017) and earned his doctorate in 2017. He specializes in ceramic implants and biological dentistry, combining aesthetics, function, and health, and has been practicing in Tübingen since 2023.

@ Email 🔗 Website

Dr. Dominik Nischwitz

Dr. Dominik Nischwitz is co-founder of DNA Health & Aesthetics and a leading expert in biological dentistry and ceramic implants. He serves as Vice President of ISMI, is an international speaker and author, and integrates health, aesthetics, and function for long-term oral and overall wellness.

@ Email 🔗 Website